Cyclacel Pharmaceuticals (FRA:UXI) Cash Flow for Dividends : €-0.14 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Cyclacel Pharmaceuticals Cash Flow for Dividends?

Cyclacel Pharmaceuticals's cash flow for dividends for the three months ended in Mar. 2024 was €0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.14 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Cyclacel Pharmaceuticals's quarterly payment of dividends declined from Sep. 2023 (€-0.05 Mil) to Dec. 2023 (€-0.05 Mil) and declined from Dec. 2023 (€-0.05 Mil) to Mar. 2024 (€0.00 Mil).

Cyclacel Pharmaceuticals's annual payment of dividends increased from Dec. 2021 (€-0.18 Mil) to Dec. 2022 (€-0.19 Mil) but then declined from Dec. 2022 (€-0.19 Mil) to Dec. 2023 (€-0.18 Mil).

Cyclacel Pharmaceuticals Cash Flow for Dividends Historical Data

The historical data trend for Cyclacel Pharmaceuticals's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyclacel Pharmaceuticals Cash Flow for Dividends Chart

Cyclacel Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Dividends

Get a 7-Day Free Trial

-0.18

-0.17

-0.18

-0.19

-0.18

Cyclacel Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash Flow for Dividends	Get a 7-Day Free Trial															-0.05	-0.05	-0.05	-0.05	-

Cyclacel Pharmaceuticals Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.14 Mil.

Cyclacel Pharmaceuticals Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Cyclacel Pharmaceuticals's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyclacel Pharmaceuticals (FRA:UXI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyclacel Pharmaceuticals Inc (FRA:UXI) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

CYCCP.PFD:USA CYCC:USA UXI:Germany

Address

200 Connell Drive, Suite 1500, Berkeley Heights, NJ, USA, 07922

Website

https://www.cyclacel.com

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

Cyclacel Pharmaceuticals (FRA:UXI) Headlines

No Headlines